Neoplasm
RecruitingStudy of ALE.
Study of ALE.
Spain- Participants:18–64 years · 65+ years
- Substances:ALE.P03
- Sponsor:Alentis Therapeutics AG
Rare diseases
Investigational molecules
Locations
Back to Spain582 clinical trials in Cordoba, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Study of ALE.
Spain
SpainA Study of Puxitatug Samrotecan Compared to Chemotherapy for Patients with Advanced Endometrial Cancer After Previous Platinum and Immunotherapy Treatment
SpainA study testing DFL24498 eye drop solution to improve eye itching in adults with atopic keratoconjunctivitis
SpainA study to evaluate the long-term safety and effectiveness of afimkibart in patients with atopic dermatitis who took part in previous afimkibart studies
SpainA Study of Belzutifan and Zanzalintinib Compared to Cabozantinib in Patients with Advanced Kidney Cancer that Returned After Previous Treatment
SpainA study comparing trifluridine, tipiracil, and fruquintinib versus trifluridine and tipiracil alone for patients with metastatic stomach or esophageal cancer
SpainA study comparing montelukast to placebo for reducing pain in patients with erosive osteoarthritis of the hands
SpainStudy of chemotherapy drug combination with or without heated chemotherapy in the abdomen for patients with advanced colon cancer
SpainA Study of IMVT-1402 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy to Prevent Disease Relapse
SpainA study comparing BNT323 with chemotherapy in patients with HER2-expressing recurrent endometrial cancer who received previous treatment
SpainStudy of IMVT-1402 in Adults with Mild to Severe Generalized Myasthenia Gravis
SpainThe busiest research cities in the country
What the registry says about research in the country
Advanced clinical trials focusing on novel treatments for various cancer types, including metastatic colorectal cancer, non-small cell lung cancer, and prostate cancer. Studies evaluate innovative therapeutic approaches and combination treatments.
Investigations include targeted therapies and immunotherapy combinations for improved patient outcomes.
Comprehensive research into autoimmune conditions, including systemic sclerosis, atopic dermatitis, and psoriatic arthritis. Clinical trials evaluate new biological treatments and their effectiveness.
Focus on developing targeted treatments for chronic inflammatory conditions.
Vaccine development studies targeting cytomegalovirus (CMV) and respiratory syncytial virus (RSV). Research aims to prevent infections in vulnerable populations.
Emphasis on vaccine efficacy and safety in different age groups.
Tell us about your condition – we search every trial in Europe and connect you with the right site.